2-Amino-cyclopent-1-ene-1-thiocarboxylic acid-disulfides to treat
noradrenergic malfunctions
    3.
    发明授权
    2-Amino-cyclopent-1-ene-1-thiocarboxylic acid-disulfides to treat noradrenergic malfunctions 失效
    2-氨基 - 环戊-1-烯-1-硫代羧酸 - 二硫化物,用于治疗去甲肾上腺素能异常

    公开(公告)号:US4200650A

    公开(公告)日:1980-04-29

    申请号:US6523

    申请日:1979-01-25

    IPC分类号: A61K31/195

    CPC分类号: A61K31/195

    摘要: New 2-amino-cyclopent-1-ene-thiocarboxylic acid-disulfides of the general formula (I), ##STR1## wherein R is hydrogen, a C.sub.1-6 alkyl group having optionally a C.sub.1-4 alkoxy, hydroxy, carboxy and/or amino substituent, a C.sub.2-4 alkenyl group, a C.sub.3-8 cycloalkyl group or phenyl group, are prepared by oxidizing the respective 2-amino-cyclopent-1-ene-dithiocarboxylic acids of the general formula (II), ##STR2## wherein R is as defined above. The new compounds of the general formula (I) and their salts exert dopamine-.beta.-hydroxylase inhibiting effects and can be applied in the therapy.

    摘要翻译: 通式(I)的新的2-氨基 - 环戊-1-烯 - 硫代羧酸 - 二硫化物,其中R是氢,任选具有C1-4烷氧基的C1-6烷基,羟基, 羧基和/或氨基取代基,C2-4烯基,C3-8环烷基或苯基,通过将通式(II)的各个2-氨基 - 环戊-1-烯 - 二硫代羧酸氧化, (II)其中R如上定义。 通式(I)的新化合物及其盐可发挥多巴胺-β-羟化酶的抑制作用,可用于治疗。